(Q68803408)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

title

Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: I. Reduction of autoantibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

author name string

Gunn HC

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

publication date

1 May 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

27 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

page(s)

225-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3488856%20AND%20SRC:MED&resulttype=core&format=json

Biological effects of cyclosporin A: A new antilymphocytic agent

27 September 2019

cites work

1 reference

12 December 2020

Treatment of lupus nephritis

1 reference

12 December 2020

Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.

1 reference

12 December 2020

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

1 reference

12 December 2020

Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A.

1 reference

12 December 2020

Treatment of experimental myasthenia gravis with cyclosporin A

1 reference

12 December 2020

NIH conference. Systemic lupus erythematosus: insights from animal models

1 reference

12 December 2020

Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice

1 reference

12 December 2020

Systemic lupus erythematosus: 25 years of treatment related to immunopathology.

1 reference

12 December 2020

Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment

1 reference

12 December 2020

Modulation of Experimental Autoimmune Uveitis With Cyclosporin A

1 reference

12 December 2020

From our laboratories: cyclosporin A.

1 reference

12 December 2020

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

12 December 2020

Cyclosporin relieves arthralgia, causes angioedema

1 reference

12 December 2020

Studies on the Mechanism of Action of Cyclosporin A

1 reference

12 December 2020

Reversal of nzb/nzw disease with total lymphoid irradiation

1 reference

12 December 2020

Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells

1 reference

12 December 2020

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

12 December 2020

Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens

1 reference

12 December 2020

Effects of the new anti-lymphocytic peptide cyclosporin A in animals

1 reference

12 December 2020

Identifiers

1 reference